{"name":"Nanjing IASO Biotechnology Co., Ltd.","slug":"nanjing-iaso-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CAR-GPRC5D","genericName":"CAR-GPRC5D","slug":"car-gprc5d","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Eque-cel CAR-T Therapy","genericName":"Eque-cel CAR-T Therapy","slug":"eque-cel-car-t-therapy","indication":"Relapsed or refractory B-cell lymphoma","status":"phase_2"}]}],"pipeline":[{"name":"CAR-GPRC5D","genericName":"CAR-GPRC5D","slug":"car-gprc5d","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Eque-cel CAR-T Therapy","genericName":"Eque-cel CAR-T Therapy","slug":"eque-cel-car-t-therapy","phase":"phase_2","mechanism":"CAR-T cell therapy targets CD19-positive B cells","indications":["Relapsed or refractory B-cell lymphoma","Relapsed or refractory diffuse large B-cell lymphoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNOE8xWVNjdkdXd0owTVE5NFFtMk5jRExrLU92TnJSeEdJc2duOFBaTXlPcEk0ZnVNQXdyUk02Vm5xenJwUGdLN1BVazQ4VDVaYTQzb0drcFVtZ1NYT1NjUkRfTlhHNkUzcTVGcW12V1hIV1Y1Zlo2TTNVOUQ4OVQzamZFMGRiZ0FFa0FDQTYxLS1yWnFHYU8yM1Frb1YzX1VoTHRPdFZyQ3FacjBWeG93Y2x0dVZ1RWhSZWRnX1BaVEV5ck0?oc=5","date":"2025-10-29","type":"deal","source":"PR Newswire","summary":"IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea - PR Newswire","headline":"IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOTFRWdk1faWotclNmbkphcC1XeHJ0R0s0UnkyYnF6LVBrQjEycDZJSERQZnk4ZktwUTBHbG1wVTFSU1FxOHVTWUx3WTFnd2I3VlpnWDVEbUVEU05NN29zWlA3ZkFkMWU3YmotRno2S29NdUhWRTJadnc3SzFacVhnTjRwODJENnZXYVh4QzYxSjIwMG4zMnNjaG94VXdRellLZW5PbkpwTnY5RGl3VTlpUW5jYmtDb09iTTg5RHQ0ZG9tTDl0Zk1GQV9nS1R5WUxsOXpkeWtRcURYVEJvQ0dmNnZZSXlYUnBobk1PYw?oc=5","date":"2025-10-06","type":"pipeline","source":"PR Newswire","summary":"Lupus Nephritis Market to Advance at a CAGR of 8.5% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Lupus Nephritis Market to Advance at a CAGR of 8.5% During the Forecast Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE8wWk1YNUM2V0dHMS16MWx4MVhFcVljU0hKRDBfNWFZYjAyV1ZrWVN6elU3bWw3bkxOTWpPQ3I5VXRIV2tOWUFmdUZEMW1oMkNBTzU4Ulh2QjhqZXRGWDNZSFFBU05QMWhjRHlubXFTRjE1VWVaeFNPTUtaUUM?oc=5","date":"2025-06-19","type":"pipeline","source":"ThinkChina","summary":"Chinese biotech is having a ‘DeepSeek moment’ - ThinkChina","headline":"Chinese biotech is having a ‘DeepSeek moment’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNOXcyek5vakItWXNwTWFOdFM3OEhGZmJieFYxLWl4dDRmNnlaNGN4cXZxM2VyRjMzUnBKa1dobmdmbnZIekUxR2F5eFpiQmRicGcwTlMyUVN3Zkk4aHBFYWM0ZnZnNUg0XzZTNktyeFQ1SUw3cmx0VldjdjhGeUwzNk5FNlVFekUxb0cxdUNrUVBaS3FLc1Ixa0lIZmRqRG83VlpPdWlBVk9fN1NhZzBFMlgzWkQxN01hMkhfM094d3hWSG9nOW1BMFlJQUk2TlJjbjZiN1U2NXhEU19HdXRveDNNdGp0S08yRlUzVDZNQ1VQUHpONmNNazhtcjI?oc=5","date":"2025-03-24","type":"pipeline","source":"PR Newswire","summary":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight - PR Newswire","headline":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQV1JBcWNmYk85cFJyVU9PYzE1c0x3b2RjcW9fN1JUQ1FNc1BRUjNMRkltMTl3cHZCdnpoOHFvQlFCY3BrQ0ZWa1lxQnNCb055NlZyVlcwelZGd1hxRmhCVnBybXdSS1B3eFJZT1JUV0JfWGFEM2Vvc3ZJNzdRdUlPcmR4YkJjSEEyWGhIYm0xZkk0cXJLTzNXeXR3anY5cjA4eEQwbzNVWjUtSWxDdm55Ti0zWFh3TW8zUnlRcmpVTFhQc0NCMmJydTdVUzBYbXdGbGR5R2xPeWNLX3VuV0t6bWduNW1GYnhSYl8zbmFfa2lteDBGTzNtQUlKNHlOczZjYXFISHdpc3dtUm9IY0FCNmQwZ2hPeEhYdTAwaFFwTXlGd2Z4NHdpbUxiZXU1dGM5UjBrVjQ2UTc5QlJkM0NyUVlQWnBQTkU?oc=5","date":"2025-03-05","type":"trial","source":"GlobeNewswire","summary":"CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"CAR T-cell Therapy Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNcThTYnBTaFZXUXdNYzlhY0ZBdUlXNzE4cnVhSzlCVFF1T0JEeG9odldXSWtaYkQ4UmlCbzJrVVFsVWZMc0x5d1UxZkRXeUhsNTNnYkUySHNOOTZGZzVCYkNhMlBPRm1rUWpVNU9VUGhuRTlQQms4TnlpVnJEd0QyeENydmtnZkRNdmNDT0FIN3dvMVJ5SXNfS1pTTnBFWW53Y0RTazN6a2tQRXQ4ZnQwN0luYm9HTkxydE1EVVpWeS0zam9NRXp1UHlETlBkUWxYUmJIcTRvQkpyQVRLVjdIVWlqZ2U2dUtYbXVqUnhXamZVWlVSM25jT0tjX1Y0SC13dWNB?oc=5","date":"2025-03-05","type":"pipeline","source":"PR Newswire","summary":"XPOVIO Continues to Disrupt the Oncology Market with Expanded Indications and Strong Market Performance | DelveInsight - PR Newswire","headline":"XPOVIO Continues to Disrupt the Oncology Market with Expanded Indications and Strong Market Performance | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQYXlpWWtJNGNLZHJEeWRMRnR6R0E2SVY5eElibzV2ZDlyaGZ0cDNLd3Z4V2hIVWpoZlA1LUw5SEd6SHRHbWNva1VQcUExU1FQN1lWV3pBN2M4aUktay16cGpCc2pPc2xsOWlwUzBvMXFGbmduaG5OdE1mZEM5aEdlN3BsNU1LNER4eWtScEpHb1hKUllUWm1OSndEM3MySmF6d3VPY0Q5ZVFjclBWUG5TMGNpODhhYWdiUlFQbV94T0g1T3RyZ2FnOWlhS0Z1c0xpNnExUGJBMTJfSGNGR01paGlveU5mazNqMV9JM1FIX1FlSzUwSjJ4VEtBWjVtWTVfTmpteW9n?oc=5","date":"2024-11-19","type":"regulatory","source":"PR Newswire","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - PR Newswire","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPVkRMZTFPNWRnTEliZmx2X2haQUE0ZHJ6TWlGM1V4OElCRjVGMVE4VlpSN0NKLW5hd1pZbHR3QWFQbU1NUHAyWldwd0ZaTVpMY1ZBaFlWU3ZZbHpZVkJsRUtEWnB6XzIyTFlPRGdYVmpHakR6RUVWdWxVcnppcm9neEtOaGIwT0lUZnFrWXJ4TmhuVlZlU1pUcEl2X0Z3VERmdW1ydXA1RmR3WkxqZUtwTUpYTkFISU94YjRYSGRCZnNfaUhRV1l3SzhIN29yd1hGblhqa2lVOEFLMXlxeU1FUVo5clhTY1JpMjUzbFpyOFVxMGctczBwZlZNTjJJMjgwSnppaGM1T2pJbjdBckV4ZnRtTTZVVUl1cG1mS1hlX2w?oc=5","date":"2024-10-22","type":"trial","source":"GlobeNewswire","summary":"Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire","headline":"Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}